Publication:
Coronary-artery bypass surgery in patients with left ventricular dysfunction

dc.contributor.authorEric J. Velazquezen_US
dc.contributor.authorKerry L. Leeen_US
dc.contributor.authorMarek A. Dejaen_US
dc.contributor.authorAnil Jainen_US
dc.contributor.authorGeorge Sopkoen_US
dc.contributor.authorAndrey Marchenkoen_US
dc.contributor.authorImtiaz S. Alien_US
dc.contributor.authorGerald Pohosten_US
dc.contributor.authorSinisa Gradinacen_US
dc.contributor.authorWilliam T. Abrahamen_US
dc.contributor.authorMichael Yiien_US
dc.contributor.authorDorairaj Prabhakaranen_US
dc.contributor.authorHanna Szweden_US
dc.contributor.authorPaolo Ferrazzien_US
dc.contributor.authorMark C. Petrieen_US
dc.contributor.authorChristopher M. O'Connoren_US
dc.contributor.authorPradit Panchavinninen_US
dc.contributor.authorLilin Sheen_US
dc.contributor.authorRobert O. Bonowen_US
dc.contributor.authorGena Roush Rankinen_US
dc.contributor.authorRobert H. Jonesen_US
dc.contributor.authorJean Lucien Rouleauen_US
dc.contributor.otherDuke University School of Medicineen_US
dc.contributor.otherDuke Clinical Research Instituteen_US
dc.contributor.otherSlaski Uniwersytet Medyczny w Katowicachen_US
dc.contributor.otherInstytut Kardiologii im. Prymasa Tysiaclecia Stefana Kardynala Wyszynskiegoen_US
dc.contributor.otherSAL Hospital and Medical Instituteen_US
dc.contributor.otherCenter for Chronic Disease Controlen_US
dc.contributor.otherNational Heart, Lung, and Blood Instituteen_US
dc.contributor.otherNovosibirsk Research Institute of Circulation Pathology Academician EN Meshalkina (NNIIPK)en_US
dc.contributor.otherDalhousie Universityen_US
dc.contributor.otherKeck School of Medicine of USCen_US
dc.contributor.otherUniversity of Belgradeen_US
dc.contributor.otherOhio State Universityen_US
dc.contributor.otherUniversity of Melbourneen_US
dc.contributor.otherOspedali Riuniti Di Bergamoen_US
dc.contributor.otherGolden Jubilee National Hospitalen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNorthwestern Universityen_US
dc.contributor.otherInstitut de Cardiologie de Montrealen_US
dc.date.accessioned2018-05-03T08:32:47Z
dc.date.available2018-05-03T08:32:47Z
dc.date.issued2011-04-28en_US
dc.description.abstractBACKGROUND: The role of coronary-artery bypass grafting (CABG) in the treatment of patients with coronary artery disease and heart failure has not been clearly established. METHODS: Between July 2002 and May 2007, a total of 1212 patients with an ejection fraction of 35% or less and coronary artery disease amenable to CABG were randomly assigned to medical therapy alone (602 patients) or medical therapy plus CABG (610 patients). The primary outcome was the rate of death from any cause. Major secondary outcomes included the rates of death from cardiovascular causes and of death from any cause or hospitalization for cardiovascular causes. RESULTS: The primary outcome occurred in 244 patients (41%) in the medical-therapy group and 218 (36%) in the CABG group (hazard ratio with CABG, 0.86; 95% confidence interval [CI], 0.72 to 1.04; P = 0.12). A total of 201 patients (33%) in the medical-therapy group and 168 (28%) in the CABG group died from an adjudicated cardiovascular cause (hazard ratio with CABG, 0.81; 95% CI, 0.66 to 1.00; P = 0.05). Death from any cause or hospitalization for cardiovascular causes occurred in 411 patients (68%) in the medical-therapy group and 351 (58%) in the CABG group (hazard ratio with CABG, 0.74; 95% CI, 0.64 to 0.85; P < 0.001). By the end of the follow-up period (median, 56 months), 100 patients in the medical-therapy group (17%) underwent CABG, and 555 patients in the CABG group (91%) underwent CABG. CONCLUSIONS: In this randomized trial, there was no significant difference between medical therapy alone and medical therapy plus CABG with respect to the primary end point of death from any cause. Patients assigned to CABG, as compared with those assigned to medical therapy alone, had lower rates of death from cardiovascular causes and of death from any cause or hospitalization for cardiovascular causes. (Funded by the National Heart, Lung, and Blood Institute and Abbott Laboratories; STICH ClinicalTrials.gov number, NCT00023595.) Copyright © 2011 Massachusetts Medical Society.en_US
dc.identifier.citationNew England Journal of Medicine. Vol.364, No.17 (2011), 1607-1616en_US
dc.identifier.doi10.1056/NEJMoa1100356en_US
dc.identifier.issn15334406en_US
dc.identifier.issn00284793en_US
dc.identifier.other2-s2.0-79955494359en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/12534
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79955494359&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleCoronary-artery bypass surgery in patients with left ventricular dysfunctionen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79955494359&origin=inwarden_US

Files

Collections